18 unknown. 18 Phase 2, 6 Phase 3, 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 18 | Unknown 18 |
| Phase 3 | 6 | Unknown 6 |
| Phase 1 | 4 | Unknown 4 |
Follow Wound Infection: new trials by email Literature Review of Wound Infection trials Research Report on Wound Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Prophylactic Antibiotic in Subtalar Fusion Surgery Ceftriaxone 2000 mg - Surgical Site Infection | Phase 2 / Phase 3 | Unknown | Assiut University | 102 | 2024-09-01 | 2024-07-30 |
| Clinical Trial to Demonstrate the Safety and Efficacy of DUOFAG® IMP, Placebo - Surgical Site Infection, Staphylococcus Aureus Infection | Phase 1 / Phase 2 | Unknown | MB PHARMA s.r.o. | 52 | 2023-10-27 | 2024-03-19 |
| The Use of Steri3X for Prevention of Post-operative Wound Infections in Cesarean Sections Steri3X, Control - Surgical Site Infection, Cesarean Section; Complications, Wound, Infection (Following Delivery) | Phase 2 | Unknown | University of Tennessee | 1000 | 2023-02-07 | 2023-02-13 |
| Phage Therapy for the Prevention and Treatment of Pressure Ulcers. Bacteriophage-loaded Microcapsule Spray, Placebo, Standard of Care - Pressure Ulcer | Phase 1 / Phase 2 | Unknown | Precisio Biotix Therapeutics, Inc. | 69 | 2022-01-01 | 2021-12-21 |
| Tumescent Anesthesia Antibiotic Delivery (TAAD) Tumescent Anesthesia and antibiotic delivery (TAAD) plus IVAD, SubQKath - Surgical Site Infection, Thrombosis | Phase 2 / Phase 3 | Unknown | HK Surgical, Inc. | 330 | 2021-12-01 | 2021-02-02 |
| Difference of Surgical Site Infection Between Using Sodium Picosulfate Solution(PicosolutionⓇ) and Oral Sulfate Tablet(ORA·FANGⓇ) in Colorectal Cancer Surgery Oral Sulfate Tablet(ORA·FANGⓇ), Sodium Picosulfate Solution(PicosolutionⓇ) - Colorectal Cancer | Phase 2 | Unknown | National Cancer Center, Korea | 414 | 2020-11-01 | 2020-10-20 |
| Topical Gentamicin and Vancomycin for Vascular Surgical Site Infection Prophylaxis Topical vancomycin paste (1g vancomycin powder + 4mL sterile saline) and Collatamp G gentamicin-eluting sponge (Azralez Pharmaceuticals; 2.0mg gentamicin sulphate/cm2 to cover wound) - Vascular Diseases, Peripheral Vascular Disease | Phase 2 / Phase 3 | Unknown | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 356 | 2020-05-01 | 2020-01-30 |
| Two-drug Antibiotic Prophylaxis in Scheduled Cesarean Deliveries Azithromycin 500 mg, Mefoxin 2g - Endometritis, Cesarean Section; Infection | Phase 2 | Unknown | RWJ Barnabas Health at Jersey City Medical Center | 800 | 2019-09-15 | 2019-09-17 |
| Single Dose Cefepime Versus Cefuroxime Plus Metronidazole as a Prophylactic Antibiotic During Emergency Intrapartum Cesarean Section Cefepime, Cefuroxime plus Metronidazole - Emergency Cesarean Section, Infection Wound | Phase 2 / Phase 3 | Unknown | Assiut University | 500 | 2019-07-01 | 2019-07-05 |
| Intrawound Vancomycin Prophylaxis for Neural Stimulator Vancomycin Hydrochloride, Saline Solution - Vancomycin, Implantable Neural Stimulator | Phase 2 / Phase 3 | Unknown | University of British Columbia | 900 | 2017-09-15 | 2020-10-30 |
| Tumescent Antibiotic Delivery for Prevention of Surgical Site Infection Concomitant Tumescent Antibiotic Delivery & IV Delivery, Subcutaneous Tumescent Infiltration, cecefazolin and metronidazole (in a dilute solution of tumescent lidocaine, epinephrin and sodium bicarbonate in 0.9% physiologic saline) - Surgical Site Infections, Venous Thromboembolism | Phase 2 / Phase 3 | Unknown | Klein, Jeffrey A., M.D. | 400 | 2015-10-01 | 2015-07-21 |
| Evaluation of Phage Therapy for the Treatment of Escherichia Coli and Pseudomonas Aeruginosa Wound Infections in Burned Patients E. coli Phages cocktail, Standard of care : Silver Sulfadiazine, P. Aeruginosa, Phages cocktail - Wound Infection | Phase 1 / Phase 2 | Unknown | Phagenix | 2015-07-01 | 2015-07-24 | |
| Quick Skin Sealant in Closure of Surgical Wound After Laparoscopic Surgery Laparoscopic surgery, Skin sealant - Complications of Surgical Procedures, Surgical Site Infection | Phase 2 | Unknown | First Affiliated Hospital, Sun Yat-Sen University | 100 | 2015-02-01 | 2015-08-13 |
| Negative Pressure Wound Therapy for the Prevention of Surgical Site Infection Following Lower Limb Revascularization Prevena (Negative Pressure Wound Therapy Device), Standard Tegaderm (3M Healthcare, St. Paul, MN) adhesive dressing - Surgical Wound Infection, Peripheral Vascular Diseases | Phase 1 / Phase 2 | Unknown | Western University, Canada | 80 | 2014-07-01 | 2015-07-31 |
| Chlorhexidine Versus Povidone-Iodine Antisepsis for Reduction of Post Cesarean Section Surgical Site Infection Chlorhexidine, Povidone-Iodine - Surgical Site Infection | Phase 2 | Unknown | Ain Shams Maternity Hospital | 410 | 2014-06-01 | 2015-03-24 |
| Abdominal Wall Closure With Triclosan-coated Suture (TCS09-10) abdominal wall closure - Wound Infection | Phase 2 | Unknown | University of Pecs | 1 | 2009-11-01 | 2010-05-14 |
| Wound Antiseptic Study With Hypochlorous Acid & Iodopovidone Hypochlorous acid, Iodopovidone - Surgical Site Infection | Phase 2 | Unknown | Universidad Tecnológica de Pereira | 432 | 2008-07-01 | 2008-10-21 |
| Prevention of Gastrostomy-Related Wound Infection by Vancomycin in Carriers of Methicillin-Resistant Staphylococcus Aureus. Vancomycin - Wound Infection | Phase 2 | Unknown | University Hospital, Geneva | 96 | 2004-09-01 | 2005-12-29 |
Surgical Wound Infection (13) · Infections (3) · Colorectal Neoplasms (2) · Peripheral Vascular Diseases (2) · Pseudomonas Infections (2) · Staphylococcal Infections (2) · Bacterial Infections (1) · Cross Infection (1) · Diverticulum (1) · Endometritis (1) · Gastrointestinal Stromal Tumors (1) · Inflammatory Bowel Diseases (1) · Pressure Ulcer (1) · Sepsis (1)
Infections (15) · Pathologic Processes (13) · Pathological Conditions, Signs and Symptoms (13) · Postoperative Complications (13) · Cardiovascular Diseases (4) · Vascular Diseases (3) · Bacterial Infections and Mycoses (2) · Colonic Diseases (2) · Digestive System Diseases (2) · Digestive System Neoplasms (2) · Embolism and Thrombosis (2) · Gastrointestinal Diseases (2) · Gastrointestinal Neoplasms (2) · Gram-Negative Bacterial Infections (2)
Metronidazole (2) · Povidone-Iodine (2) · Vancomycin (2) · 1,3,4,6-tetra-O-acetyl-2-azido-2-deoxyglucopyranose (1) · Azithromycin (1) · Cefepime (1) · Cefoxitin (1) · Ceftriaxone (1) · Cefuroxime (1) · Chlorhexidine (1) · Epinephrine (1) · Hypochlorous Acid (1) · Inosine Monophosphate (1) · Laparoscopy (1) · Negative-Pressure Wound Therapy (1)
Assiut University (2) · Ain Shams Maternity Hospital (1) · First Affiliated Hospital, Sun Yat-Sen University (1) · HK Surgical, Inc. (1) · Klein, Jeffrey A., M.D. (1) · London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (1) · MB PHARMA s.r.o. (1) · National Cancer Center, Korea (1) · Phagenix (1) · Precisio Biotix Therapeutics, Inc. (1) · RWJ Barnabas Health at Jersey City Medical Center (1) · Universidad Tecnológica de Pereira (1) · University Hospital, Geneva (1) · University of British Columbia (1) · University of Pecs (1)
Canada (2) · Egypt (2) · France (2) · Switzerland (2) · United States (2) · Belgium (1) · China (1) · Colombia (1) · Czechia (1) · Hungary (1) · South Korea (1)
Adam Power, MD (1) · Alain Vonlaufen, MD (1) · Gina Suh, M.D. (1) · Hector Bolivar, M.D. (1) · Hyoung-Chul Park, Doctor (1) · Juliana Buitrago, MD.,MSc (1) · Karin Zachow, M.D. (1) · Luc Dubois, MD, MSc (1) · Ors Peter Horvath, MD, PhD, DSc (1) · Patrick Jault, MD (1) · Ramona Phinehas, MD (1) · Robert Staffa, prof. (1) · Tali Wajsfeld, MD (1) · Wael Y Eladly (1)
PMID 40260835, PMID 10219875, PMID 12573039, PMID 15855756, PMID 17588420, PMID 18338205, PMID 18560962, PMID 18636300, PMID 19231586, PMID 25631195, PMID 26229155, PMID 26537879, PMID 28865981, PMID 30292481, PMID 32580252, PMID 38022210, PMID 41159585